Paradeep Phosphates reports strong Q2 FY26 results, approves ₹3,600 crore capex for expansion and appoints new directors
Paradeep Phosphates announced strong Q2 FY26 results, revenue increased to ₹6,872.20 crore. The board also approved ₹3,600 crore capex for new plants and appointed two additional directors.
The approval of ₹3,600 crore in capital expenditure for backward integration and capacity expansion is a significant strategic move, indicating substantial future investment and potential for enhanced operational capabilities and profitability. The strong financial performance further reinforces this high impact.
The company reported a significant increase in both standalone and consolidated revenue and profit for Q2 and half-year ended September 30, 2025. Additionally, the approval of a substantial ₹3,600 crore capital expenditure for new granulation, phosphoric, and sulphuric acid plants signifies strategic growth and backward integration, which is a positive long-term outlook.
* Paradeep Phosphates Limited's Board of Directors, at their meeting held on November 6, 2025, approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. * The company reported strong financial performance for the quarter ended September 30, 2025: * Standalone Revenue from operations increased to ₹6,872.20 crore, up from ₹4,619.16 crore in the corresponding quarter of the previous year. * Standalone Profit for the period rose to ₹341.93 crore, compared to ₹255.16 crore in Q2 FY25. * Consolidated Revenue from operations was ₹6,872.20 crore, significantly higher than ₹4,619.16 crore in Q2 FY25. * Consolidated Profit for the period reached ₹341.94 crore, an increase from ₹255.33 crore in Q2 FY25. * The Board approved a total estimated capital expenditure (capex) of ₹3,600 crore for strategic expansion projects: * Installation/execution of a fully Integrated Granulation plant at the Paradeep site with an estimated capex of ₹2,450 crore. * Installation/execution of a Phosphoric & Sulphuric Acid plant at the Mangalore site with an estimated capex of ₹1,150 crore. * The rationale for this capex is to achieve 100% backward integration for fertilizer production, reduce import dependency, and enhance operational capabilities and profitability. The proposed capacity additions are expected to be completed within 2.5 years. * The Board also approved key appointments, effective November 6, 2025: * Mr. Akshay Poddar (DIN: 00008686) was appointed as an Additional Director (Non-Executive) and Vice Chairman of the Company, subject to shareholder approval. * Mrs. Ruchira Kamboj (DIN: 11068450) was appointed as an Additional Director (Non-Executive) in the category of Independent Director for a term of 5 years, subject to shareholder approval.
What to do with a filing like this
Paradeep Phosphates Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Paradeep Phosphates Limited. Read the original for the full detail.